List Name |
Annotation |
Enrichment |
p-value |
myelination |
AmiGO Browser |
17.34 |
7.03e-04 |
long-chain fatty acid metabolic process |
AmiGO Browser |
44.95 |
8.60e-04 |
axon ensheathment |
AmiGO Browser |
13.79 |
1.38e-03 |
ensheathment of neurons |
AmiGO Browser |
13.79 |
1.38e-03 |
regulation of action potential |
AmiGO Browser |
10.11 |
3.35e-03 |
vasculogenesis |
AmiGO Browser |
13.48 |
9.70e-03 |
somatic recombination of immunoglobulin genes during immune response |
AmiGO Browser |
13.48 |
9.70e-03 |
isotype switching |
AmiGO Browser |
13.48 |
9.70e-03 |
somatic diversification of immunoglobulins during immune response |
AmiGO Browser |
13.48 |
9.70e-03 |
immunoglobulin production during immune response |
AmiGO Browser |
13.48 |
9.70e-03 |
tetracycline transport |
AmiGO Browser |
101.14 |
9.86e-03 |
somatic cell DNA recombination |
AmiGO Browser |
13.05 |
0.01 |
somatic diversification of immune receptors via germline recombination within a single locus |
AmiGO Browser |
13.05 |
0.01 |
somatic recombination of immunoglobulin gene segments |
AmiGO Browser |
13.05 |
0.01 |
RNA localization |
AmiGO Browser |
6.60 |
0.01 |
somatic diversification of immunoglobulins |
AmiGO Browser |
11.90 |
0.01 |
somatic diversification of immune receptors |
AmiGO Browser |
11.90 |
0.01 |
nucleobase, nucleoside, nucleotide and nucleic acid transport |
AmiGO Browser |
6.13 |
0.01 |
immunoglobulin production |
AmiGO Browser |
10.37 |
0.02 |
lymphocyte mediated immunity |
AmiGO Browser |
5.23 |
0.02 |
leukocyte mediated immunity |
AmiGO Browser |
4.89 |
0.02 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
AmiGO Browser |
40.45 |
0.02 |
production of molecular mediator of immune response |
AmiGO Browser |
7.93 |
0.03 |
drug transport |
AmiGO Browser |
33.71 |
0.03 |
cytoskeleton-dependent intracellular transport |
AmiGO Browser |
4.37 |
0.03 |
immune effector process |
AmiGO Browser |
4.24 |
0.03 |
organelle fission |
AmiGO Browser |
25.28 |
0.04 |
protein amino acid glycosylation |
AmiGO Browser |
3.89 |
0.04 |
biopolymer glycosylation |
AmiGO Browser |
3.84 |
0.04 |
copper ion transport |
AmiGO Browser |
20.23 |
0.05 |
peptidyl-histidine modification |
AmiGO Browser |
20.23 |
0.05 |
copper ion homeostasis |
AmiGO Browser |
20.23 |
0.05 |
dendrite morphogenesis |
AmiGO Browser |
20.23 |
0.05 |
glycoprotein biosynthetic process |
AmiGO Browser |
3.70 |
0.05 |
muscle cell differentiation |
AmiGO Browser |
5.47 |
0.05 |
regulation of progression through S phase |
AmiGO Browser |
18.39 |
0.05 |
superoxide release |
AmiGO Browser |
18.39 |
0.05 |
regulation of S phase of mitotic cell cycle |
AmiGO Browser |
18.39 |
0.05 |
regulation of transcription from RNA polymerase III promoter |
AmiGO Browser |
18.39 |
0.05 |
mRNA transport |
AmiGO Browser |
5.25 |
0.06 |
regulation of oxidoreductase activity |
AmiGO Browser |
16.86 |
0.06 |
C21-steroid hormone biosynthetic process |
AmiGO Browser |
16.86 |
0.06 |
synaptic vesicle exocytosis |
AmiGO Browser |
16.86 |
0.06 |
serine family amino acid biosynthetic process |
AmiGO Browser |
16.86 |
0.06 |
regulation of calcium ion transport |
AmiGO Browser |
16.86 |
0.06 |
glycosphingolipid biosynthetic process |
AmiGO Browser |
16.86 |
0.06 |
immunoglobulin mediated immune response |
AmiGO Browser |
5.12 |
0.06 |
B cell mediated immunity |
AmiGO Browser |
5.12 |
0.06 |
protein stabilization |
AmiGO Browser |
15.56 |
0.06 |
lipid biosynthetic process |
AmiGO Browser |
2.71 |
0.06 |
protein polymerization |
AmiGO Browser |
4.93 |
0.06 |
response to protein stimulus |
AmiGO Browser |
4.87 |
0.06 |
response to unfolded protein |
AmiGO Browser |
4.87 |
0.06 |
cation transport |
AmiGO Browser |
2.13 |
0.07 |
RNA transport |
AmiGO Browser |
4.70 |
0.07 |
establishment of RNA localization |
AmiGO Browser |
4.70 |
0.07 |
JNK cascade |
AmiGO Browser |
4.70 |
0.07 |
nucleic acid transport |
AmiGO Browser |
4.70 |
0.07 |
glycolipid biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
posttranslational protein folding |
AmiGO Browser |
13.48 |
0.07 |
stress-activated protein kinase signaling pathway |
AmiGO Browser |
4.55 |
0.07 |
fatty acid biosynthetic process |
AmiGO Browser |
4.45 |
0.08 |
protein folding |
AmiGO Browser |
2.54 |
0.08 |
regulation of ion transport |
AmiGO Browser |
12.64 |
0.08 |
glycoprotein metabolic process |
AmiGO Browser |
3.05 |
0.08 |
di-, tri-valent inorganic cation transport |
AmiGO Browser |
3.02 |
0.08 |
ganglioside metabolic process |
AmiGO Browser |
11.90 |
0.08 |
sulfur amino acid biosynthetic process |
AmiGO Browser |
11.90 |
0.08 |
metal ion transport |
AmiGO Browser |
2.17 |
0.08 |
regulation of cell growth |
AmiGO Browser |
2.93 |
0.08 |
patterning of blood vessels |
AmiGO Browser |
11.24 |
0.09 |
regulation of DNA recombination |
AmiGO Browser |
11.24 |
0.09 |
natural killer cell mediated cytotoxicity |
AmiGO Browser |
11.24 |
0.09 |
S phase of mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
natural killer cell mediated immunity |
AmiGO Browser |
11.24 |
0.09 |
negative regulation of progression through mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
S phase |
AmiGO Browser |
11.24 |
0.09 |
carboxylic acid biosynthetic process |
AmiGO Browser |
4.05 |
0.09 |
organic acid biosynthetic process |
AmiGO Browser |
4.05 |
0.09 |
negative regulation of gene expression, epigenetic |
AmiGO Browser |
10.65 |
0.09 |
positive regulation of protein secretion |
AmiGO Browser |
10.65 |
0.09 |
regulation of exocytosis |
AmiGO Browser |
10.65 |
0.09 |
axon guidance |
AmiGO Browser |
3.89 |
0.09 |
C21-steroid hormone metabolic process |
AmiGO Browser |
10.11 |
0.09 |
negative regulation of programmed cell death |
AmiGO Browser |
2.33 |
0.10 |
leukocyte mediated cytotoxicity |
AmiGO Browser |
9.63 |
0.10 |
sphingolipid biosynthetic process |
AmiGO Browser |
9.63 |
0.10 |
regulation of protein stability |
AmiGO Browser |
9.63 |
0.10 |
response to metal ion |
AmiGO Browser |
9.63 |
0.10 |
regulation of programmed cell death |
AmiGO Browser |
1.79 |
0.10 |
NADP metabolic process |
AmiGO Browser |
9.19 |
0.10 |
microtubule-based movement |
AmiGO Browser |
3.68 |
0.10 |